Blood Culture Tests Market worth USD 10,009.0 million by 2030

The Market Statsville Group (MSG) publishes the new report on the "Blood Culture Tests Market by Product (Consumables, Instruments, and Software and Services), by Method (Conventional and Automated), by Application (Bacterial, Fungal, and Others), by Region – Global Share and Forecast to 2030".

The global blood culture tests market size was USD 4,913.9 million in 2021 and is estimated to reach USD 10,009.0 million by 2030, and growing at a CAGR of 9.3% during the forecast period (2022-2030). Rise in geriatric population across the world is the major factor that drives the growth of the global blood culture tests market, as aged people are highly susceptible to develop immunosenescence in which the immune system does not function properly and decreases in activity of immunity system, making them people more prone to infection. In addition, the prevalence of sepsis is significantly high among the geriatric population, owing to repeated and prolonged hospitalization stay and co-existing comorbidities.

Global Blood Culture Tests Market Segments

The blood culture tests market has been segmented into the product, method, application, and region.

• By Product (Consumables, Instruments, and Software and Services)
• By Method (Conventional and Automated)
• By Application (Bacterial, Fungal, and Others)
• By Region (Noth America, Europe, Asia Pacific, South America, and Middle East & Africa)

Conventional, by method, is estimated to hold the largest market share during the forecast period

On the basis of method, the global blood culture tests market is bifurcated into conventional and automated. The conventional segment held the highest market share of 70.5% in 2021 and is expected to remain dominant throughout the forecast period. Conventional is the process of incubating the bottle at the required atmosphere and temperature for microscopic evidence of growth of microorganisms which form colonies and turbidity. This procedure serves as the simplest method, and hence has its application in various hospitals, pathology laboratories, and independent clinical laboratories.

In addition, the demand for conventional method is increasing for evaluating the result of blood culture and infection controls. The Thermo Fisher Scientific Inc., one of the leading company in serving science, announced Signal Blood Culture System, which uses the manual/conventional method and culture a wide range of micro-aerophilic organisms, aerobes, and anaerobes in single bottles.

Don't miss out on business opportunities in Blood Culture Tests Market. Speak to our research analyst and gain crucial market insights that will benefit your business grow.

North America accounts for the largest market share

Based on the regions, the global blood culture tests market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, North America accounted had the largest market share of 39.5% in the global blood culture tests market. The North America blood culture test market is studied across the U.S., Canada, and Mexico. The market in North America is expected to hold the substantial share throughout the forecast period due to the presence of developed healthcare infrastructure. North America is the top manufacturing hub for blood culture test, which drives the growth of the market.

In addition, the presence of target population base, increase in awareness regarding healthcare sector, and rise in disposable income across the region are expected to support the market growth. For instance, as per the data published by the Health and Human Services (HHS), in the U.S., about 20% increase was registered in Medicare enrollment rates. However, a 40% rise was witnessed in the rate of sepsis-related hospital admissions among the beneficiaries in 2018. Around 270,000 Americans die every year as a result of sepsis. This is expected to propel the demand for blood culture tests in the coming years.

This research report includes an examination of the leading companies' development and marketing strategies, as well as an examination of their product portfolios and winning strategies in the blood culture tests market. It also consists of the profiles of leading companies such as Becton, Dickinson and Company, Luminex Corporation, T2 Biosystems, Inc., Bruker Corporation, bioMerieux SA, F. Hoffmann-La Roche Ltd, Autobio Diagnostics Co., Ltd., Neogen Corporation (Abtek Biologicals), OpGen Inc., and Thermo Fisher Scientific Inc.

Browse the complete report: https://www.marketstatsville.com/blood-culture-tests-market

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

416, East Standsberry Street, Perkins, Oklahoma 74059, USA

USA: +1-580-205-2707 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com